These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [News on ASCO 2007. Sunitinib in the treatment of metastatic renal carcinoma and gastrointestinal stromal tumors]. Mansueto G; Longo F Tumori; 2007; 93(5):Suppl 1-16. PubMed ID: 18038894 [No Abstract] [Full Text] [Related]
3. Dose matters: the importance of appropriate dosing: a case report on sunitinib treatment in a patient with metastatic renal cell carcinoma. Bojic M; Schmidinger M Clin Genitourin Cancer; 2012 Dec; 10(4):277-9. PubMed ID: 22658385 [No Abstract] [Full Text] [Related]
4. Phase III study of sunitinib malate (SU11248) versus interferon-alpha as first-line treatment in patients with metastatic renal cell carcinoma. Reddy K Clin Genitourin Cancer; 2006 Jun; 5(1):23-5. PubMed ID: 16859575 [No Abstract] [Full Text] [Related]
19. Recent aspects of sunitinib therapy in patients with metastatic clear-cell renal cell carcinoma: a systematic review of the literature. Minardi D; Quaresima L; Santoni M; Bianconi M; Scartozzi M; Cascinu S; Muzzonigro G Curr Urol Rep; 2015 Feb; 16(2):3. PubMed ID: 25627021 [TBL] [Abstract][Full Text] [Related]